I ntroduction: The invention and use of antibiotics in treating infections is one of the greatest achievements of the twentieth century medicine. Antibiotics are one of the categories of pharmaceuticals with a broad and increasing application. Goal: The goal of this paper is to analyze the influence of different set of test concentrations of ceftriaxone antibiotics on the occurrence of chromosome aberrations after in vitro treatment with concentrations: 0.15mg/ml, 0.25mg/ml and 0.50mg/ml. Materials and Methods: In the study was used the blood of healthy donors in vitro, treated with different concentrations of ceftriaxone. Ceftriaxone is a semisynthetic cephalosporine third generation antibiotic, with broad spectrum of activity and with specific characteristics (Nerlove et al. 1996). As a biomarker of genetic damage are used the methods of cultivation of peripheral blood lymphocytes and analysis of chromosome aberrations. Cytogenetic analysis of ceftriaxone genotoxicity was performed in 48-hour culture of human peripheral blood lymphocytes by test of standard chromosome aberration analysis according to Moorhead, with certain modifications. Insight into the frequency and type of chromosome aberrations is obtained by analyzing 100 metaphases per sample. Results: By the analysis of 100 metaphases per sample was determined that the relative frequency of metaphases with chromosome aberrations is increased with increasing concentrations of ceftriaxone in lymphocyte culture. The increase in the frequency of structural aberrations was also positively correlated with the applied ceftriaxone concentrations. Metaphases with numerical and structural aberrations are registered in lymphocyte cultures treated with ceftriaxone concentration of 0.25 mg/ml and 0.50 mg/ml, but this increase was not significant compared to the control cells cultures. Conclusions: Significantly increased frequency of metaphases with structural chromosome aberrations in cultured human peripheral blood lymphocytes treated with concentrations of 0.25 mg/ml and 0.5 mg/ml compared to the control confirming clastogenic potential of this drug. Ceftriaxone also expressed aneugenic activity at the highest test concentration (0.50mg/ml), confirming a statistically significant difference in the frequency of numerical aberrations in cultures treated with doses of 0.5mg/ml.
INTRODUCTION
Modern man is every day exposed to chemicals from the environment, by profession, therapy, or due to changes in lifestyle. Studies conducted on bacteria in mammals in vivo and in vitro cell cultures have confirmed that many chemicals interact with genetic material, causing DNA damage (1) .
Modern scientific research in the fields of pharmacy, medicine, biochemistry are designed to be performed on the cultures of isolated cells in order to study the effect of a number of agents at the cellular, sub cellular, or molecular level, the gene level and initiate mechanisms of cell response to the action of many exogenous/endogenous agents, thus genotoxicology, a scientific branch of toxicology, becomes more and more important (2) .
Although the tests for the genotoxins detection are numerous and various, until today single test that would fully satisfy all requirements is not found.
Generally, cephalosporines are group of antibiotics which does not show genotoxic potential (3) .
However, the results of cytogenetic studies indicate potential genotoxic and mutagenic effects of certain cephalosporines during an experimental treatment in repeated doses, doses higher than recommended, as in animals (4, 5) as well as in humans (6) .
There is no information about the negative effects on the fetus or newborn (7, 8, 9) .
The results of some studies, which included the Ames test, micronucleus test and a test for chromosome aberrations in cultured human lymphocytes in vitro, show no genotoxic potential and mutagenic effects of ceftriaxone in a single therapeutic dose (10, 11) .
GOALS
According to the type of the research, the primary goal of this study was:
To determine the intensity of the ceftriaxone genotoxic potential, from cephalosporine group of antibiotics in human cells in vitro;
Based on the nature, frequency and expressivity of observed eff ects to evaluate whether this drug contributes to increasing genetic load in human populations.
Th e study is in line with the set objectives conducted using standard test for chromosome aberration analysis.
MATERIALS AND METHODS
This is a research of ceftriaxone genotoxicity in vitro in human cells, on which in the recent literature there is no exact data.
Ceftriaxone is a semisynthetic cephalosporine third generation antibiotic, with broad spectrum of activity and with specifi c characteristics (12) .
Generic name: Ceftriaxone. The structural formula has presented on Schema 1.
Cytogenetic analysis of ceftriaxone genotoxicity was performed on peripheral blood samples of 10 healthy volunteer donors (5 ♂ ♂ 5 ♀ ♀), aged 30-40 years at the time of sampling, all nonsmokers.
For the purposes of this research were elected healthy subjects whose occupation is not linked with exposure to chemical and physical agents that could aff ect the value of cytogenetic fi ndings, respondents who in the previous year were not exposed to medical procedures with X-rays, or are taking longterm medication which mechanisms of action could result in elevated values of analyzed cytogenetic biomarkers.
Th is research was conducted at the Center for Genetics, Faculty of Medi- 
Goals
 To determine the intensity of the ceftriaxone genotoxic potential, from cephalosporin group of antibiotics in human cells in vitro;
 Based on the nature, frequency and expressivity of observed effects to evaluate whether this drug contributes to increasing genetic load in human populations.
The study is in line with the set objectives conducted using standard test for chromosome aberration analysis.
Materials and methods
Ceftriaxone is a semisynthetic cephalosporin third generation antibiotic, with broad spectrum of activity and with specific characteristics (12).
Generic name: Ceftriaxone
The structural formula is: For each control (without drug treatment) and experimental treatment with the selected test concentrations of ceftriaxone: 0.15, 0.25 and 0.50 mg/ ml, was seeded whole blood under sterile conditions, and in the shortest period in sterile conditions are set the cell cultures.
Schema 1. Structural formula of Ceftriaxone
Cultivation of peripheral blood lymphocytes was performed using the standard procedure by Moorhead (13), with certain modifications, adapted to our laboratory conditions.
Preparations were analyzed by immersion lens with 900x enlargement, at the electric light microscope and photographed using digital camera.
Review of preparations included an analysis of the morphology and the number of chromosomes in 100 metaphases for each control and sample treated with ceftriaxone.
Registered aberrations are classified in accordance with the International System of Nomenclature (ISCN) (14) (16) .
To determine the statistical significance of the difference between the arithmetic mean of the results of analysis of chromosome aberrations between control and cultures treated with the test ceftriaxone concentrations, the analysis of variance (ANOVA) and Student Newman-Keuls multiple comparisons were used.
The results of this test are graphically represented on Whisker-Box diagrams using MedCalc Version 12.5.0.0 software. These diagrams show the range, frequency between the 25 and 75 percentile and the median value for all parameters. Table 1 provides a detailed overview of determined chromosome aberrations in control cultures and cultures of lymphocytes treated with selected concentrations of ceftriaxone.
RESULTS
An analysis of 100 metaphases per sample determined that the relative frequency of metaphases with chromosome aberrations increased with increasing concentrations of ceftriaxone in lymphocyte culture (Table 2) .
By applying the test of analysis of variance (ANOVA) and Student-Newman-Keuls test at significance level of p<0.05, significant difference was found in the frequency of metaphases with chromosome aberrations in cultures with each of the applied concentration compared to the control, as well as the frequency of metaphases with chromo- Table 3 . Frequencies of metaphases with structural chromosome aberrations at 100 analyzed metaphases in control and lymphocyte cultures treated with selected concentrations of ceftriaxone The frequency of structural chromosomal aberrations also increased with increasing concentrations of ceftriaxone (Table 3) . some aberrations between each of the treated cultures (Figure 1 ). The frequency of structural chromosomal aberrations also increased with increasing concentrations of ceftriaxone (Table 3) .
Analysis of variance for frequency of metaphases with structural aberrations, at the level of significance of p <0.05 are shown in Figure 2 The various types of registered structural chromosome aberrations in the control group showed the presence of acentric fragments (4), and by one chromatoid break and dicentric chromosome (Table 4) .
Metaphases with numerical and structural aberrations are registered in lymphocyte cultures treated with ceftriaxone at concentration of 0.25 mg/ml and 0.50 mg/ml, but this increase was not significant compared to the control lymphocyte culture (Table 5) .
Applying ANOVA test, followed by Student-Newman Keuls test confirmed the significance of the difference in frequency of metaphases with both types of chromosome aberrations in lymphocyte cultures treated with the highest concentration of ceftriaxone (0.50mg/ ml) in relation to cultures traded with a lower concentration of ceftriaxone ( Figure 3) .
Of numerical aberrations in the cultures treated with ceftriaxone in concentration of 0.25mg/ml was found one polyploidy and one aneuploidy (47 chromosomes). It is interesting that only one registered aneuploidy also existed for higher concentrations of ceftriaxone in the same subject.
DISCUSSION
Chromosome aberrations are manifested in the form of deviations from the normal structure or number of chromosomes. These microscopically detectable changes in chromosomes have a significant role as an indicator of genotoxicity.
Frequency of chromosome aberrations in the normal population has a wide range of variation and may be the result of differences between laboratories in the conditions of cultivation and characteristics of the sample.
Chromosome effects of ceftriaxone are manifested by appearance both structural and numerical aberrations. Qualitative and quantitative expression of the perceived effect is correlated with the intensity of the concentration.
In this research was present both clastogenic and aneugenic potential of ceftriaxone. Much stronger is clastogenic nature of ceftriaxone genotoxic potential in lymphocyte cultures in this study, which was confirmed by a higher frequency of structural aberrations in relation to numerical chromosome aberrations.
Our findings indicate a stronger clastogenic in relation to aneugenic activity of ceftriaxone. As the concentration of ceftriaxone in cultured human peripheral blood lymphocytes increases the frequency of chromosome aberrations in 100 metaphases (control Xav = 0.7, at the concentration of 0.15mg/ml = 3.1, concentration of 0.25mg/ml = 4.5, 0.50mg/ml concentration = 9.7).
Frequency of numerical aberrations is correlated with ceftriaxone concentrations tested, but it is much smaller compared to structural aberrations.
Chromosome instability is associated with susceptibility for the development of cancer. The results of some studies show a statistical association between the occurrence of cancer and the presence of chromosome aberrations, but not of chromatoid type (17, 18) .
Powerf ul clastogenic potential of ceftriaxone in cultures of peripheral blood lymphocytes, which is demonstrated in this study shows that it can be correlated with the same or similar action of antibiotics such as penicillin (19) or chloramphenicol (20) .
In our study aberrations of chromosomal type are with higher frequencies compared to aberrations of chromatoid type, unlike some other antibiotics where the vast majority of structural (Table 4) . aberrations represented aberrations of chromatoid type (6) . Our findings indicate that the effect of ceftriaxone is independent of the S-phase of the cell cycle (or DNA synthesis), since it induced breaks in DNA that were detected only in the first metaphase after exposure as:
• Chromosome aberrations (symmetrical); • Chromatoid aberrations (asymmetric).
CONCLUSIONS
On the basis of the analysis of chromosome aberrations in cultured human peripheral blood lymphocytes treated with test concentrations of ceftriaxone, and by testing the significance of differences between the observed frequency of cytogenetic parameters by analysis of variance (ANOVA) and Student-Newman Keuls test, it is possible to derive several conclusions:
Significantly is increased the frequency of metaphases with structural chromosome aberrations in cultured human peripheral blood lymphocytes treated with concentrations of 0.25 mg/ ml and 0.50 mg/ml compared to the control, confirming clastogenic potential of this drug.
Ceftriaxone also showed aneugenic activity at the highest test concentration (0.50mg/ml), confirming a statistically significant difference in the frequency of numerical aberrations in cultures treated with doses of 0.50mg/ml.
Frequency and expressiveness of observed effects are directly related with the concentrations.
Based on the results it can be found a need for more detailed examination of this drug on a larger number of samples, concentrations and the tests in order to obtain a more complete picture of its effects on the organism after its application. 
